Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of Transcription Activator-like Effector Nucleases T512 in HPV16-infected Subjects

NCT03226470 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT03226470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of Transcription Activator-like Effector Nucleases T512 in HPV16-infected Subjects
Lead sponsor
Huazhong University of Science and Technology
Phase
Phase 1
Overall status
Unknown status
Start date
March 10, 2017
Completion date
June 10, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus-related malignant neoplasm